Kemin invests in China to drive enzyme innovation, expand product portfolio

Kemin Industries, a global ingredient manufacturer, has entered into a new partnership with CRVAB Bio-technology Co. Ltd. based in Chifeng, Inner Mongolia, China.

Since 1980, Kemin has been a global market leader in blending enzymes for feed. It offers more than 500 specialty ingredients for human and animal health, pet foods, nutraceuticals, food technology, crop technologies and textiles.

Kemin will have expanded resources for innovations in both single and blended enzymes, as well as probiotic product pipelines as the company works on a new product portfolio to bring enzyme products to market. The investment will give Kemin one of the most efficient fermentation facilities in China and an accelerated ability to bring products to Kemin customers.

“With this investment, we will be able to better serve more customers in the global feed enzymes markets and will become basic in enzyme production,” Chris Nelson, president and CEO of Kemin Industries, said in a released statement. Nelson holds a Ph.D. in biochemistry and biophysics from Washington State University.

Peijun Wu, chairman of CRVAB Bio-technology Company Ltd., said, “We are very excited to have Kemin as a trusted partner. This will significantly improve our capability and allow us to produce products meeting the highest international quality standards.”

“As the feed and animal production industry continues to evolve, customers are searching more aggressively for innovations that add real value,” said GS Ramesh, Kemin global group president, animal nutrition and health. “Kemin continues to be the key driver of product and technology innovations globally. This new partnership will further strengthen our capability to quickly scale up new innovations, while maintaining our quality and safety standards for global regulatory requirements.”

Source: Kemin Industries